KBC Group NV Acquires Shares of 1,214 Astrana Health, Inc. (NASDAQ:ASTH)

KBC Group NV bought a new stake in Astrana Health, Inc. (NASDAQ:ASTH) in the 3rd quarter, Holdings Channel.com reports. The fund bought 1,214 shares of the company’s stock, valued at approximately $70,000.

Several other large investors have also made changes to their positions in the company. SteelPeak Wealth LLC acquired a new stake in Astrana Health in the third quarter worth about $39,398,000. NorthCrest Asset Manangement LLC acquired a new stake in shares of Astrana Health during the 3rd quarter worth approximately $26,704,000. Principal Financial Group Inc. acquired a new stake in shares of Astrana Health during the 3rd quarter worth approximately $13,383,000. F M Investments LLC bought a new stake in shares of Astrana Health during the third quarter worth approximately $11,738,000. Finally, Diamond Hill Capital Management Inc. acquired a new position in Astrana Health in the third quarter valued at approximately $8,245,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

Analyst Upgrades and Downgrades

ASTH has been the subject of several recent research reports. BTIG Research upped their target price on shares of Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research report on Thursday, October 3rd. Robert W. Baird increased their target price on Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a research note on Wednesday, November 13th. TD Cowen assumed coverage on Astrana Health in a report on Monday, October 14th. They set a “buy” rating and a $66.00 target price on the stock. KeyCorp began coverage on Astrana Health in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. Finally, Stifel Nicolaus lifted their price objective on shares of Astrana Health from $48.00 to $60.00 and gave the stock a “buy” rating in a research note on Thursday, August 1st. One equities research analyst has rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Astrana Health currently has a consensus rating of “Buy” and a consensus price target of $65.17.

Astrana Health Stock Performance

NASDAQ:ASTH opened at $42.11 on Friday. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91. The business’s 50-day simple moving average is $54.41 and its 200-day simple moving average is $47.77. Astrana Health, Inc. has a fifty-two week low of $32.32 and a fifty-two week high of $63.20. The stock has a market capitalization of $2.37 billion, a PE ratio of 32.49, a price-to-earnings-growth ratio of 1.90 and a beta of 1.24.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.33. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The firm had revenue of $478.71 million for the quarter, compared to analyst estimates of $462.01 million. During the same quarter in the previous year, the firm posted $0.47 earnings per share. Sell-side analysts expect that Astrana Health, Inc. will post 1.17 earnings per share for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.